The 2024 AHA/ACC clinical guidelines provide updated recommendations for perioperative cardiovascular medication management in patients undergoing noncardiac surgery.
Provides a concise summary of the latest AHA/ACC guidelines for managing cardiovascular medications during the perioperative period of noncardiac surgery.
This JAMA Clinical Guidelines Synopsis summarizes the 2024 recommendations from the American Heart Association and American College of Cardiology on perioperative cardiovascular medication management for noncardiac surgery.
“There is a wealth of new evidence about how best to evaluate and manage perioperative cardiovascular risk in patients undergoing noncardiac surgery. Worldwide, there are approximately 300 million noncardiac surgeries each year, which underscores the need to summarize and interpret the evidence to assist clinicians in managing patients who present for surgery. This new guideline is a comprehensive review of the latest research to help inform clinicians who manage perioperative patients, with the ultimate goal of restoring health and minimizing cardiovascular complications.”
Winchester et al. (2026) studied this question. The 2024 AHA/ACC clinical guidelines provide updated recommendations for perioperative cardiovascular medication management in patients undergoing noncardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: